HappeningToo topic
Peginterferon Alfa-2a reports
Browse community reports connected to Peginterferon Alfa-2a. These reports can show that other people are describing similar experiences, but they do not prove that Peginterferon Alfa-2a caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
47 problems
Abdominal Discomfort while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and abdominal discomfort appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and abdominal distension appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and abdominal pain upper appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and abdominal pain appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and alopecia appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and anxiety appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and back pain appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and chills appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and constipation appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and cough appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and decreased appetite appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and dehydration appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and diarrhea appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and dizziness appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and dry mouth appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and dry skin appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and dyspepsia appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and excessive sweating appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and fatigue appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and feeling abnormal appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and headache appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and hives appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Influenza Like Illness while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and influenza like illness appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and insomnia appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Irritability while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and irritability appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and itching appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and malaise appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and muscle spasms appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and myalgia appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and nausea appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and oropharyngeal pain appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and pain appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and peripheral swelling appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash Erythematous while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and rash erythematous appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash Papular while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and rash papular appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and rash appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and shortness of breath appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and skin redness appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and sleepiness appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Taste changes while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and taste changes appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and tingling or pins and needles appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and tremor appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and vision blurred appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and vomiting appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and weakness appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and weight decreased appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Peginterferon Alfa-2a
FDA FAERS contains adverse-event reports in which Peginterferon Alfa-2a and weight increased appear together. This does not establish that Peginterferon Alfa-2a caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →